Achilles Therapeutics plc (ACHL) Ownership

$1.38

south_east
-$0.01 (-0.72%)
Day's range
$1.38
Day's range
$1.39

Achilles Therapeutics plc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SYNCONA PORTFOLIO LTD 02/06/2025 11.09 M $12.64 M   0.00% 27.42%
BML CAPITAL MANAGEMENT, LLC 02/07/2025 4.10 M $4.67 M   0.00% 10.14%
FCPM III SERVICES B.V. 02/14/2025 2.39 M $2.75 M   0.00% 5.91%
REDMILE GROUP, LLC 02/14/2025 1.61 M $1.83 M   0.00% 3.98%
VESTAL POINT CAPITAL, LP 02/14/2025 1.50 M $1.71 M   0.00% 3.71%
IKARIAN CAPITAL, LLC 02/14/2025 1.44 M $1.64 M   -0.14% 3.56%
SIREN, L.L.C. 02/14/2025 755,375 $861,128   0.00% 1.87%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 547,233 $623,846   -14.24% 1.35%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 418,441 $477,023   -0.49% 1.04%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 191,829 $218,000   -23.52% 0.47%
TWO SIGMA INVESTMENTS, LP 02/14/2025 61,637 $70,266   190.07% 0.15%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 50,189 $57,215   100.00% 0.12%
TWO SIGMA ADVISERS, LP 02/14/2025 34,200 $38,988   52.68% 0.08%
XTX TOPCO LTD 02/13/2025 26,824 $30,579   100.00% 0.07%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 21,590 $24,612   0.00% 0.05%
BRAVE ASSET MANAGEMENT INC 01/14/2025 10,000 $11,400   0.00% 0.02%
RHUMBLINE ADVISERS 01/30/2025 4,480 $5,106   0.00% 0.01%
02/06/2025 322 $367   100.00% 0.00%
JPMORGAN CHASE & CO 02/12/2025 137 $156   0.00% 0.00%
ARCADIA INVESTMENT MANAGEMENT CORP/MI 02/03/2025 0 $0   -100.00% 0.00%
CORSAIR CAPITAL MANAGEMENT, L.P. 02/14/2025 0 $0   -100.00% 0.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 0 $0   -100.00% 0.00%
BAADER BANK AKTIENGESELLSCHAFT 01/23/2025 0 $0   -100.00% 0.00%

Achilles Therapeutics plc institutional Ownership - FAQ's

During the previous two years, 26 institutional investors and hedge funds held shares of Achilles Therapeutics plc. The most heavily invested institutionals were:

Syncona Portfolio Ltd: 11.09 M

BML Capital Management, LLC: 4.1 M

FCPM III SERVICES B.V.: 2.39 M

Redmile Group, LLC: 1.61 M

Vestal Point Capital, LP: 1.5 M

Ikarian Capital, LLC: 1.44 M

60.10% of Achilles Therapeutics plc stock is owned by institutional investors.

Institutional investors have bought a total of 24.26 M shares in the last 24 months. This purchase volume represents approximately $33.49 M in transactions.